Mehmet Ozturk

Cited by

	All	Since 2016
Citations	10471	1807
h-index	46	22
i10-index	91	43

460

230

115

345

1987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202126 37 30 54 115 323 364 382 401 293 310 278 321 349 324 354 285 335 308 369 309 302 309 306 382 400 429 452 398 337 349 358 337 308 117

Public access

View all

5 articles

1 article

available

not available

Based on funding mandates

Co-authors

Jack Wandsprofessor of medicine,Brown UniversityVerified email at brown.edu
Rengul Cetin AtalayUniversity of Chicago and Middle East Technical UniversityVerified email at metu.edu.tr
Dominique BELLETProfesseur d'immunologie, Université Paris DescartesVerified email at parisdescartes.fr
Serif SenturkResearch Group Leader at Izmir Biomedicine and Genome CenterVerified email at ibg.edu.tr
Ozge gursoy YuzugulluDana Farber Cancer Institute, Harvard Medical SchoolVerified email at dfci.harvard.edu
Frederique PonchelThe University of Leeds (LIRMM, TRIMID)Verified email at leeds.ac.uk
YAKICIERProfessor of Molecular Biology and Genetics ACIBADEM UniversityVerified email at acibadem.com.tr
HALUK YUZUGULLUAstrazeneca PharmaceuticalsVerified email at astrazeneca.com
Hiroshi TakahashiTexas Instruments JapanVerified email at ti.com
Cigdem Ozen, Ph.D.TU Dresden, Bioinformatics, Center for Molecular and Cellular Bioengineering (CMCB)Verified email at tu-dresden.de
Nuri OzturkProfessor @ Gebze Technical UniversityVerified email at gtu.edu.tr
Tamer YagciVerified email at gyte.edu.tr
Ayça Arslan ErgülUNAM, Bilkent UniversityVerified email at bilkent.edu.tr
Gokhan YildizKaradeniz Technical University School of Medicine Department of Medical BiologyVerified email at ktu.edu.tr
Hilal Ozdag PhDAnkara University Biotechnology InstituteVerified email at ankara.edu.tr
Isik G. YulugAssociate Professor of Molecular Biology and Genetics, Bilkent UniversityVerified email at fen.bilkent.edu.tr
Bert VogelsteinJohns HopkinsVerified email at jhmi.edu
Tolga CagatayUT Southwestern Medical Center at DallasVerified email at utsouthwestern.edu
Berna S. SayanUniversity of ManchesterVerified email at manchester.ac.uk
Mustafa YilmazHarvard UniversityVerified email at fas.harvard.edu

Mehmet Ozturk

Izmir Biomedicine and Genome Center, Dokuz Eylul University, Izmir, Turkey

Verified email at deu.edu.tr - Homepage

Molecular Biology Genetics Cell Biology Cancer


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Selective G to T mutations of p 53 gene in hepatocellular carcinoma from southern Africa B Bressac, M Kew, J Wands, M Ozturk Nature 350 (6317), 429-431, 1991	1669	1991
p53 functions as a cell cycle control protein in osteosarcomas. L Diller, J Kassel, CE Nelson, MA Gryka, G Litwak, M Gebhardt, B Bressac, ... Molecular and cellular biology 10 (11), 5772-5781, 1990	968	1990
p53 mutation in hepatocellular carcinoma after aflatoxin exposure B Bressac, A Puisieux, M Kew, M Volkmann, S Bozcall, JB Mura, ... The Lancet 338 (8779), 1356-1359, 1991	565	1991
P53 HOTSPOT MUTATION IN HEPATOCELLULAR-CARCINOMA IS LINKED TO AFLATOXIN EXPOSURE M Ozturk, B BRESSAC, A Puisieux, M Kew, M Volkmann, S Bozcali, ... HEPATOLOGY 14 (4), A94-A94, 1991	565*	1991
Abnormal structure and expression of p53 gene in human hepatocellular carcinoma B Bressac, KM Galvin, TJ Liang, KJ Isselbacher, JR Wands, M Ozturk Proceedings of the National Academy of Sciences 87 (5), 1973-1977, 1990	520	1990
Identification of BTG2, an antiproliferative p53–dependent component of the DNA damage cellular response pathway JP Rouault, N Falette, F Guéhenneux, C Guillot, R Rimokh, Q Wang, ... Nature genetics 14 (4), 482-486, 1996	463	1996
Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens A Puisieux, S Lim, J Groopman, M Ozturk Cancer research 51 (22), 6185-6189, 1991	365	1991
Human MLH1 deficiency predisposes to hematological maligancy and neurofibromatosis type 1 MD Ricciardone, T Özçelik, B Cevher, H Özdağ, M Tuncer, A Gürgey, ... Cancer research 59 (2), 290, 1999	281	1999
Systems medicine and integrated care to combat chronic noncommunicable diseases J Bousquet, JM Anto, PJ Sterk, IM Adcock, KF Chung, J Roca, A Agusti, ... Genome Medicine 3 (7), 1-12, 2011	274	2011
Genetic aspects of hepatocellular carcinogenesis. M Ozturk Seminars in liver disease 19 (3), 235-242, 1998	246	1998
Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells H Yuzugullu, K Benhaj, N Ozturk, S Senturk, E Celik, A Toylu, N Tasdemir, ... Molecular cancer 8 (1), 90, 2009	231	2009
Smad2 and Smad4 gene mutations in hepatocellular carcinoma MC Yakicier, MB Irmak, A Romano, M Kew, M Ozturk Oncogene 18 (34), 4879, 1999	212	1999
Genetic heterogeneity of hepatocellular carcinoma H Unsal, C Yakicier, C Marcais, M Kew, M Volkmann, H Zentgraf, ... Proceedings of the National Academy of Sciences 91 (2), 822-826, 1994	201	1994
PATIKA: an integrated visual environment for collaborative construction and analysis of cellular pathways E Demir, O Babur, U Dogrusoz, A Gursoy, G Nisanci, R Cetin-Atalay, ... Bioinformatics 18 (7), 996-1003, 2002	199	2002
Transforming growth factor‐beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growth S Senturk, M Mumcuoglu, O Gursoy‐Yuzugullu, B Cingoz, KC Akcali, ... Hepatology 52 (3), 966-974, 2010	191	2010
Evaluation of cytotoxicity and oxidative DNA damaging effects of di (2-ethylhexyl)-phthalate (DEHP) and mono (2-ethylhexyl)-phthalate (MEHP) on MA-10 Leydig cells and … P Erkekoglu, W Rachidi, OG Yuzugullu, B Giray, A Favier, M Ozturk, ... Toxicology and applied pharmacology 248 (1), 52-62, 2010	183	2010
Redundant expression of canonical Wnt ligands in human breast cancer cell lines K Benhaj, KC Akcali, M Ozturk Oncology reports 15 (3), 701-707, 2006	177	2006
Physiological studies of human chorionic gonadotropin (hCG), αhCG, and βhCG as measured by specific monoclonal immunoradiometric assays M OZTURK, D BELLET, LUC MANIL, G HENNEN, R FRYDMAN, ... Endocrinology 120 (2), 549-558, 1987	164	1987
Retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines A Puisieux, K Galvin, F Troalen, B Bressac, C Marcais, E Galun, ... The FASEB journal 7 (14), 1407-1413, 1993	158	1993
P53 mutation as a source of aberrant β-catenin accumulation in cancer cells T Cagatay, M Ozturk Oncogene 21 (52), 7971, 2002	122	2002

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Upload PDF

Follow this author

Cited by

Co-authors